EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluation of breast‐specific marker expression in metastatic breast cancers: Correlation with subtype switch

Ronald Chan iD, Howard Leung iD, Joshua Li iD, Ivan Poon, Julia Y Tsang iD, Chun-Wai Ko, Ngou-Men Wong, Gary M Tse iD

Histopathology · 2025-03 · 86 (4) · 536-546

DOI: 10.1111/his.15358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, online erschienen am 31.10.2024. Verfasst von Ronald Chan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University …. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cheng Yue Pui Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study evaluates the utility of breast specific markers in identifying breast cancer subtypes within metastatic settings. The subtype alteration in metastatic disease and its consequent impact on breast‐specific marker expression is also examined. Materials and methods GATA‐binding protein 3 (GATA3), mammaglobin (MMG), transcriptional repressor GATA binding 1 (TRSP1) and SRY‐box transcription factor 10 (SOX10) expression were assessed in a large cohort of metastatic breast cancer (MBC) cases and correlated with the characteristics of both MBC and primary breast cancer (PBC).

Results

GATA3 was the most sensitive in MBC (83.1%), followed by TRPS1 (77.0%), MMG (58.5%) and SOX10 (7.1%). This trend was consistent in hormonal receptor (HR)+ and HR− MBC. Combining GATA3/TRPS1 yielded the highest detection rates in the overall cohort (90.1%) and HR+ MBC (97.1%), while TRSP1/MMG was most effective in HR− (76.2%) and TN (71.1%) MBC. Marker expression did not correlate with metastatic site, except SOX10 in lung metastases ( P = 0.031). Subtype discordance between MBC and PBC occurred in 43 cases (24.4%), with GATA3 expression in HR− MBC significantly linked to subtype discordance ( P = 0.005). Conversely, SOX10 expression was significantly associated with subtype concordance in HR− and TNBC ( P ≤ 0.003). Despite a higher expression of GATA3 in all HR− cases, TRSP1 outperformed GATA3 in detecting concordant HR− cases (64.0% versus 38.5%). TRPS1 and SOX10 were expressed in more than 50% of concordant TNBC cases.

Conclusions

The expression of breast‐specific markers is mainly determined by the PBC subtype. GATA3 retains high sensitivity in HR+ cancers, even after HR loss during metastasis. TRPS1 and SOX10 are identified as valuable markers in TNBC metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorBreast NeoplasmsHumansFemaleGATA3 Transcription FactorMiddle AgedAgedAdultSOXE Transcription FactorsRepressor ProteinsDNA-Binding ProteinsMammaglobin ANeoplasm MetastasisAged, 80 and over

Substanzen

Biomarkers, TumorGATA3 Transcription FactorGATA3 protein, humanSOXE Transcription FactorsSOX10 protein, humanTRPS1 protein, humanRepressor ProteinsDNA-Binding ProteinsMammaglobin A

Autor:innen und Institutionen

  • Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
  • Department of Pathology, The University of Hong Kong, Hong Kong.

ORCID-Profile: Ronald Chan, Howard Leung, Joshua Li, Julia Y Tsang, Gary M Tse

Förderung

  • Cheng Yue Pui Foundation

Zitieren

APA

Chan, R., Leung, H., Li, J., Poon, I., Tsang, J. Y., Ko, C. W., Wong, N. M., & Tse, G. M. (2025). Evaluation of breast‐specific marker expression in metastatic breast cancers: Correlation with subtype switch. Histopathology, 86(4), 536-546. https://doi.org/10.1111/his.15358

Vancouver

Chan R, Leung H, Li J, Poon I, Tsang JY, Ko CW, et al. Evaluation of breast‐specific marker expression in metastatic breast cancers: Correlation with subtype switch. Histopathology. 2025;86(4):536-546. doi:10.1111/his.15358

BibTeX
@article{Chan2025,
  author = {Chan, Ronald and Leung, Howard and Li, Joshua and Poon, Ivan and Tsang, Julia Y and Ko, Chun-Wai and Wong, Ngou-Men and Tse, Gary M},
  title = {Evaluation of breast‐specific marker expression in metastatic breast cancers: Correlation with subtype switch},
  journal = {Histopathology},
  year = {2025},
  volume = {86},
  number = {4},
  pages = {536--546},
  doi = {10.1111/his.15358}
}
Kostenlos starten →